Diagnosis: Bacterial Dysentery (Presumptive Shigellosis)
This 15-year-old male with fever and bloody stools most likely has bacterial dysentery, and should be treated empirically with azithromycin 500 mg once daily for 5 days, given the clinical presentation of fever with bloody diarrhea consistent with bacillary dysentery. 1
Clinical Reasoning
The combination of fever and bloody stools in this adolescent points strongly toward infectious dysentery rather than a complication of his renal calculi. The renal stones are likely an incidental finding or possibly suggest underlying inflammatory bowel disease 2, 3, but the acute presentation with fever and bloody diarrhea demands immediate attention to rule out life-threatening bacterial infection.
Key Diagnostic Considerations
The 2017 IDSA guidelines specify that empiric antimicrobial therapy for bloody diarrhea is indicated in ill immunocompetent patients with fever documented in a medical setting, abdominal pain, bloody diarrhea, and bacillary dysentery (frequent scant bloody stools, fever, abdominal cramps, tenesmus) presumptively due to Shigella 1.
This patient meets these criteria with:
- Documented fever
- Four episodes of bloody stools
- Age 15 years (pediatric patient)
Treatment Algorithm
First-Line Therapy: Azithromycin
For children and adolescents with bloody diarrhea and fever, azithromycin is the preferred empiric agent 1:
- Azithromycin 500 mg once daily for 5 days (or single 1-gram dose as alternative)
Rationale for Azithromycin Over Other Options
The 2017 IDSA guidelines prioritize azithromycin for pediatric patients because:
- Superior efficacy against fluoroquinolone-resistant Campylobacter (increasingly common globally) 4
- Effective against Shigella, enteroinvasive E. coli, Aeromonas, and Yersinia 4
- Better safety profile in children compared to fluoroquinolones
- Strong recommendation with moderate evidence 1
Alternative Regimens (If Azithromycin Unavailable)
Based on older guidelines, alternative pediatric regimens include 5:
- TMP-SMX: 10 mg/kg/day TMP and 50 mg/kg/day SMX in two divided doses for 5 days
- Ampicillin: 100 mg/kg/day in four divided doses for 5 days
- Nalidixic acid: 55 mg/kg/day in four divided doses for 5 days (for resistant strains)
Important caveat: These older recommendations from 1992 5 note widespread multiresistant Shigella strains, making local susceptibility patterns critical. The 2017 guidelines 1 supersede these with azithromycin as first-line.
Critical Management Steps
Immediate Actions
- Obtain stool culture and microscopy before starting antibiotics (if feasible without delaying treatment) 5, 1
- Assess hydration status and provide oral rehydration solution (ORS) for any dehydration 1
- Check for signs of sepsis - if present, obtain blood cultures and consider broader coverage 1, 6
Reassessment Protocol
- If no clinical response within 48 hours: Change antibiotic to alternative agent based on susceptibility patterns 5
- If no improvement after additional 48 hours: Refer for stool microscopy to rule out amebiasis 5
- Avoid STEC if suspected: Do NOT use antibiotics if Shiga toxin-producing E. coli (STEC) O157 or Shiga toxin 2-producing strains are suspected, as this increases risk of hemolytic uremic syndrome 1, 6
Common Pitfalls to Avoid
Do not use antimotility agents (loperamide) in children <18 years with bloody diarrhea - risk of toxic megacolon 1
Do not empirically treat for amebiasis unless microscopy shows Entamoeba histolytica trophozoites or two different antibiotics for shigellosis have failed 5
Do not delay treatment waiting for culture results in an ill-appearing patient with fever and bloody diarrhea 1
Consider the renal calculi connection: While treating the acute infection, recognize that nephrolithiasis can be an extra-intestinal manifestation of inflammatory bowel disease 2, 3. If symptoms persist or recur, gastroenterology evaluation may be warranted.